RT Book, Section A1 Malik, Atif B. A1 Sohail, Maaz A1 Bajwa, Zahid H. A2 Bajwa, Zahid H. A2 Wootton, R. Joshua A2 Warfield, Carol A. SR Print(0) ID 1131932922 T1 Botulinum Toxins for the Treatment of Headaches T2 Principles and Practice of Pain Medicine, 3e YR 2016 FD 2016 PB McGraw-Hill Education PP New York, NY SN 9780071766838 LK neurology.mhmedical.com/content.aspx?aid=1131932922 RD 2024/10/04 AB Since the 1980s, botulinum toxins (BTXs) have been used for many putative conditions that cause pain. The U.S. Food and Drug Administration (FDA) has approved BTX type A as a prophylactic treatment for headaches due to chronic migraines and approved both BTX type A and B for other medical conditions associated with pain and discomfort. Although BTX is currently not approved for any other headache disorders, it continues to be used successfully by a range of specialists to address pain control.